Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL301987 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL5696599 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL28986129 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL844952 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL4647121 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL2987259 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL1857424 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL11015848 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL30557165 | 1.00 | EPHX1 (0.70) | EPHX1ACHE | |
| SCHEMBL29027161 | 0.98 | EPHX1 (0.68) | EPHX1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112552207-A | Production method of anisyl nitrile | 郑州科旷生物科技有限公司 | 2021-03-26 | — | — | CN | claimed |
| WO-2026105037-A1 | ANTIMICROBIAL MICROFIBERS FROM ELECTROSPINNING | POLAROID THERAPEUTICS AG (CH) | 2026-05-21 | — | — | WO | disclosed |
| US-12616716-B2 | Wound healing dressings and formulations and methods of use thereof | POLAROID THERAPEUTICS AG (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4593602-A1 | ANTIMICROBIAL COATING COMPOSITIONS | Polaroid IP B.V. (NL) | 2025-08-06 | — | — | EP | disclosed |
| US-20250099646-A1 | WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF | POLAROID IP B.V. (NL) | 2025-03-27 | — | — | US | disclosed |
| US-20240358744-A1 | WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF | POLAROID IP B.V. (NL) | 2024-10-31 | — | — | US | disclosed |
| WO-2024218719-A1 | WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF | POLAROID IP B.V. (NL) | 2024-10-24 | — | — | WO | disclosed |
| US-20240130359-A1 | ANTIMICROBIAL COATING COMPOSITIONS | POLAROID IP B.V. (NL) | 2024-04-25 | — | — | US | disclosed |
| US-20240117196-A1 | ANTIMICROBIAL COATING COMPOSITIONS | POLAROID IP B.V. (NL) | 2024-04-11 | — | — | US | disclosed |
| WO-2024069491-A1 | ANTIMICROBIAL COATING COMPOSITIONS | POLAROID IP B.V. (NL) | 2024-04-04 | — | — | WO | disclosed |
| US-6998364-B2 | Process for the formation of urethane via transcarbamation | RHODIA CHIMIE (FR) | 2006-02-14 | — | — | US | disclosed |
| US-20050123505-A1 | Biodegradable hyaluronic acid derivative and biodegradable polymeric micelle composition | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2005-06-09 | — | — | US | disclosed |
| EP-1538166-A1 | Biodegradable hyaluronic acid derivative and composition containing micelles made therefom | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2005-06-08 | — | — | EP | disclosed |
| US-20040087812-A1 | Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates | VENCOREX FRANCE (FR) | 2004-05-06 | — | — | US | disclosed |
| US-20040044242-A1 | Use as catalyst for forming urethanes,of fluorinated and of trivalent metal acid salts, composition containing same and methods using same | VENCOREX FRANCE (FR) | 2004-03-04 | — | — | US | disclosed |
| US-4725680-A | AMINATION, CLEAVAGE, NEUTRALIZATION | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1988-02-16 | — | — | US | disclosed |
| US-4692550-A | Continuous process for thermal splitting of carbamic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1987-09-08 | — | — | US | disclosed |
| US-4501915-A | HEATING UREA, ALIPHATIC PRIMARY AMINE, MONOHYDRIC ALIPHATIC ALCOHOL AND TERTIARY AMINE CATALYST | ATLANTIC RICHFIELD COMPANY (US) | 1985-02-26 | — | — | US | disclosed |
| US-4482499-A | IN THE PRESENCE OF CARBON | BASF AKTIENGESELLSCHAFT (DE) | 1984-11-13 | — | — | US | disclosed |
| US-4336402-A | Process for the preparation of N-alkyl-monosubstituted carbamic acid esters | ATLANTIC RICHFIELD COMPANY (US) | 1982-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358744-A1 | WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF | CUTA, ARG1, AAAS | EPHX1 2058/4885ACHE 767/4885 |
| US-20040044242-A1 | Use as catalyst for forming urethanes,of fluorinated and of trivalent metal acid salts, composition containing same and methods using same | PHF2, UBE2T, UHRF1 | EPHX1 3358/4885ACHE 877/4885 |
| US-20240117196-A1 | ANTIMICROBIAL COATING COMPOSITIONS | CUTA, ARG1, SLC11A2 | EPHX1 4640/4885ACHE 1803/4885 |
| US-20240130359-A1 | ANTIMICROBIAL COATING COMPOSITIONS | CUTA, PUF60, ITCH | EPHX1 4509/4885ACHE 1491/4885 |
| US-20040087812-A1 | Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates | ZYX, SNX2, PRDX3 | EPHX1 1862/4885ACHE 1018/4885 |
| US-12616716-B2 | Wound healing dressings and formulations and methods of use thereof | H1-10, SFN, PTEN | EPHX1 2817/4885ACHE 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.